Mevo
PrivateLast Round
Series B
Extension
Mar 25, 2026
Total Funding Raised
$56.63M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Mevo operates in Healthcare & Life Sciences and is based in São Paulo. Its latest recorded funding round was a Series B Extension round in March 2026.
Mevo is a healthcare technology company that provides a digital prescription platform and an online pharmacy marketplace to simplify medication access and management for patients, providers, and pharmacies in Brazil.
Sector
Healthcare & Life Sciences
Verticals
Telemedicine, EHR & EMR, Patient Engagement
Business Model
B2B2C
Customer Profile
Marketplace Commission, Services & Consulting, Data as a Service
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Mevo Comparables
Compare Mevo with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Memed | 93% | |
| Olá Doutor | 79% | |
| DrFirst | 68% |
For institutional investors. Book with your work email.
Mevo Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B Extension | Mar 25, 2026 | ||||
| Series B Extension | Nov 28, 2024 | ||||
| Series B | Sep 18, 2024 | ||||
| Convertible Debt | Dec 1, 2023 | ||||
| Series A | Jul 14, 2022 | ||||
Series A | Jul 8, 2021 |
For institutional investors. Book with your work email.
Mevo Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Matrix | Series B Extension, Series B |
| Prosus | Series B Extension |
| Floating Point | Series B Extension, Series A |
| Floating Point Advisors | Series A, Series B, Series B Extension, Convertible Debt |
| Arpex Capital | Series A, Seed |
| Grupo Santa Cruz | Series A |
| LTS Investments | Series A, Seed |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 21, 2026
Monthly visitors grew 93% MoM, reaching 3.3 million.
- Mar 30, 2026
Acquired competitor Receita Digital for an undisclosed amount.
For institutional investors. Book with your work email.
Mevo Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Mevo's valuation, stock price, and market status.
Is Mevo a public or private company?
Mevo is a private company.
What is the current stock price of Mevo?
Mevo is a private company, so its shares have no public market price. Caplight tracks Mevo's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Mevo worth (valuation)?
Valuation information for Mevo is not publicly available.
Can I buy Mevo stock?
Mevo shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Mevo's last funding round?
Mevo's most recent funding round was Series B Extension on March 25, 2026.
Who are the main investors in Mevo?
Key investors in Mevo include Matrix, Prosus, Floating Point Advisors, Prosus Ventures.
Will Mevo IPO soon?
No public IPO plans have been announced for Mevo.
How can I track Mevo secondary market activity?
Caplight tracks bids, offers, and trades in Mevo's shares on secondary markets.